The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Protea Biosciences Group - Developing Molecular Technology to Assist in Drug Discovery and Diagnostics

SNNLive spoke with Stephen Turner, CEO of Protea Biosciences Group, Inc. (OTCQB: PRGB) at the LD Micro "Main Event" 2014 in Bel Air, CA.

Share With

Wednesday, February 04, 2015


© 2019 Stock News Now